Cx-501

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameCx-501
Drug Alias NameCx501Cx 501Cx-501
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsEpidermolysis Bullosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCellerix Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTigenix Sau
Active IndicationsN/A
Inactive IndicationsEpidermolysis Bullosa

Other Information

ATC CodeN/A
Related LinksN/A